Pensacola, FL — West Florida Healthcare has been awarded a three-year term of reaccreditation in stereotactic breast biopsy as the result of a recent review by the American College of Radiology (ACR).
A breast biopsy is performed to remove cells — either surgically or through a less invasive procedure involving a hollow needle — from an area in the breast suspected to be cancerous. These cells are examined under a microscope to determine a diagnosis. In stereotactic breast biopsy, a special mammography machine helps guide the radiologist’s instruments to the site of an abnormality. West Florida Healthcare strives to maximize the use of minimally invasive techniques, such as stereotactic biopsy, to limit the cosmetic effects of benign biopsies and to optimize patient care in the diagnosis and treatment of breast cancer.
The ACR gold seal of accreditation represents the highest level of image quality and patient safety. It is awarded only to facilities meeting ACR Practice Guidelines and Technical Standards after a peer-review evaluation by board-certified physicians and medical physicists who are experts in the field. Image quality, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs are assessed. The findings are reported to the ACR Committee on Accreditation, which subsequently provides the practice with a comprehensive report they can use for continuous practice improvement.
The ACR is a national professional organization serving more than 36,000 diagnostic/interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services.